Patent Assignment
Reel/Frame 037460/0806
Assignment of Assignor's Interest
Recorded: 2016-01-08
Pages: 30
Assignor
STRYKER CORPORATION
Executed: 2014-06-30
Assignee
MARIEL THERAPEUTICS, INC.
135 E. 57TH STREET, 24TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(108)
Methods of Treating Cartilage Defects
PCT:
PCT/US2005/018020 ↗
Methods for Treating Bone Tumors
PCT:
PCT/US2005/032521 ↗
Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
PCT:
PCT/US2007/025956 ↗
Bmp Mutants with Decreased Susceptibility to Noggin
PCT:
PCT/US2008/087720 ↗
Peripheral Administration of Proteins Including Tgf-Beta Superfamily Members for Treatment of Systemic Disorders and Disease
PCT:
PCT/US2010/024106 ↗
Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including Tgf-Beta Superfamily Members
PCT:
PCT/US2010/024124 ↗
Methods and Compositions for Tissue Engineering
PCT:
PCT/US2010/024726 ↗
Buffers for Controlling the Ph of Bone Morphogenetic Proteins
PCT:
PCT/US2010/049229 ↗
Bmp-7 Variants with Reduced Immunogenicity
PCT:
PCT/US2010/061437 ↗
Synthetic Bone Matrix
Patent:
5,645,591 →
Application:
07/529,852 →
Osteogenic Proteins
Patent:
5,258,494 →
Application:
07/995,345 →
Compositions and Methods for Identification and Use of Soluble Complex Forms of Osteogenic Proteins
Patent:
5,610,021 →
Application:
08/206,864 →
Matrix for the Manufacture of Autogenous Replacement Body Parts
Patent:
5,906,827 →
Application:
08/253,398 →
Morphogen-Induced Nerve Regeneration and Repair
Morphogenic Protein Screening Method
Patent:
5,650,276 →
Application:
08/278,729 →
Morphogen-Induced Dendritic Growth
Patent:
6,949,505 →
Application:
08/292,782 →
Novel Morphogen Cell Surface Receptor
Patent:
5,831,050 →
Application:
08/357,533 →
Nucleotide Sequences Encoding Osteogenic Proteins
Patent:
6,261,835 →
Application:
08/375,901 →
Method for Recombinant Production of Osteogenic Protein Op-1
Patent:
5,670,336 →
Application:
08/376,731 →
Protein-Induced Tissue Morphogenesis
Patent:
6,565,843 →
Application:
08/404,113 →
Treatment to Prevent Loss of and/or Increase Bone Mass in Metabolic Bone Diseases
Patent:
5,674,844 →
Application:
08/406,672 →
Method for Modulating Inflammatory Response Comprising Administering Morphogen
Patent:
6,194,376 →
Application:
08/414,033 →
Method for Reducing Extravasation of Effector Cells
Patent:
6,288,031 →
Application:
08/440,894 →
Synthetic Bone Matrix
Patent:
6,077,988 →
Application:
08/443,676 →
Method for Reducing Tissue Damage Associated with Ischemia-Reperfusion or Hypoxia Injury
Patent:
6,077,823 →
Application:
08/445,467 →
Morphogen-Induced Liver Regeneration
Patent:
5,849,686 →
Application:
08/445,468 →
Method of Selectively Extracting Osteogenic Protein
Patent:
5,714,589 →
Application:
08/447,570 →
Morphogenic Protein-Specific Cell Surface Receptors and Uses Therefor
Patent:
6,632,618 →
Application:
08/448,371 →
Nucleic Acids Encoding Osteogenic Proteins
Patent:
5,863,758 →
Application:
08/449,700 →
Morphogenic Protein Screening Method
Patent:
5,741,641 →
Application:
08/451,953 →
Morphogen-Enhanced Survival and Repair of Neural Cells
Patent:
6,495,513 →
Application:
08/456,033 →
Manufacture of Autogenous Replacement Body Parts
Patent:
6,027,743 →
Application:
08/458,811 →
Novel Morphogen Cell Surface Receptor
Patent:
5,861,479 →
Application:
08/459,009 →
Manufacture of Autogenous Replacement Body Parts
Patent:
6,110,482 →
Application:
08/459,129 →
Novel Morphogenic Protein Compositions of Matter
Patent:
5,834,179 →
Application:
08/459,346 →
Novel Morphogen Cell Surface Receptor and Screening for Morphen Analogs
Patent:
6,093,547 →
Application:
08/459,951 →
Morphogen Treatments for Limiting Proliferation of Epithelial Cells
Patent:
6,399,569 →
Application:
08/461,113 →
Morphogen Treatment of Gastrointestinal Ulcers
Patent:
5,972,884 →
Application:
08/461,397 →
Methods and Compositions for High Protein Production from Recombinant Dna
Patent:
5,614,385 →
Application:
08/461,666 →
Morphogen Treatment of Gastrointestinal Ulcers
Patent:
5,739,107 →
Application:
08/462,623 →
Single Chain Analogs of the Tgf-Beta Superfamily (Morphons)
Patent:
6,040,431 →
Application:
08/478,097 →
Terminally Sterilized Osteogenic Devices and Preparation Thereof
Patent:
5,674,292 →
Application:
08/478,452 →
Morphogen Treatment of Organ Implants
Patent:
6,090,776 →
Application:
08/480,515 →
Methods of Antagonizing Op-1 Binding to Cell Surface Receptor Utilizing Alk Polypeptides
Patent:
5,863,738 →
Application:
08/481,337 →
Methods and Products for Identification of Modulators of Osteogenic Protein-1 Gene Expression
Patent:
6,071,695 →
Application:
08/486,343 →
Methods and Compositions for Identifying Morphogen Analogs
Patent:
5,834,188 →
Application:
08/507,598 →
Morphogen-Responsive Regulatory Elements
Patent:
5,932,716 →
Application:
08/507,750 →
Compostions and Therapeutic Methods Using Morphogenic Proteins and Stimulatory Factors
Patent:
6,048,964 →
Application:
08/570,752 →
Morphogen Treatment for Chronic Renal Failure
Patent:
6,498,142 →
Application:
08/643,321 →
Method for Identifying and Op-1 Analog Which Binds an Alk-1 Receptor
Patent:
5,968,752 →
Application:
08/696,268 →
Compositions and Therapeutic Methods Using Morphogenic Proteins and Stimulatory Factors
Patent:
5,948,428 →
Application:
08/761,468 →
Methods and Compositions for Identifying Morphogen Analogs
Patent:
6,090,544 →
Application:
08/764,522 →
Methods and Compositions for Identifying Morphogen Analogs
Patent:
6,103,491 →
Application:
08/764,528 →
Methods and Compositions for Producing Morphogen Analogs
Patent:
6,273,598 →
Application:
08/786,284 →
Improved Osteogenic Devices and Methods of Use Thereof for Repair of Endochondral Bone and Osteochondral Defects
Method for Enhancing Functional Recovery Following Central Nervous System Ischemia or Trauma
Patent:
6,407,060 →
Application:
08/828,281 →
Novel Therapies for Chronic Renal Failure
Patent:
6,861,404 →
Application:
08/851,628 →
Methods of Using Morphogen Analogs
Patent:
6,110,460 →
Application:
08/872,859 →
Terminally Sterilized Osteogenic Devices and Preparation Thereof
Patent:
6,028,242 →
Application:
08/881,307 →
Matrix-Free Osteogenic Devices, Implants and Methods of Use Thereof
Patent:
6,281,195 →
Application:
09/019,339 →
Compositions and Therapeutic Methods Using Morphogenic Proteins and Stimulatory Factors
Patent:
5,854,207 →
Application:
09/027,873 →
Compositions and Therapeutic Methods Using Morphogenic Proteins and Stimulatory Factors
Patent:
5,916,870 →
Application:
09/158,220 →
Terminally Sterilized Osteogenic Devices and Preparation Thereof
Patent:
6,013,856 →
Application:
09/159,535 →
Compositions and Therapeutic Methods Using Morphogenic Proteins and Stimulatory Factors
Patent:
7,026,292 →
Application:
09/287,500 →
Modified Proteins of the Tgf-Beta Superfamily, Including Morphogenic Proteins
Patent:
6,846,906 →
Application:
09/374,936 →
Mutations of the C-Terminal Portion of Tgf-Beta Superfamily Proteins
Patent:
6,677,432 →
Application:
09/374,958 →
Modulators of Morphogen Expression and Methods of Identifying the Same
Patent:
6,828,095 →
Application:
09/423,821 →
Methods for Evaluating Tissue Morphogenesis and Activity
Terminally Sterilized Osteogenic Devices and Preparation Thereof
Patent:
6,461,630 →
Application:
09/450,541 →
Methods and Compositions for Identifying Morhogenic Protein Analogs Using Morphogenic Protein Responsice Inhibitory Elements
Patent:
6,368,787 →
Application:
09/465,353 →
Single Chain Analogs of the Tgf-Beta Superfamily (Morphons)
Patent:
6,479,643 →
Application:
09/496,398 →
Synergistic Effects of Op/Bmp Morphogens and Gdnf/Ngf Neurotrophic Factors
Patent:
6,936,582 →
Application:
09/508,254 →
Compositions and Therapeutic Methods Using Morphogenic Proteins, Hormones and Hormone Receptors
Patent:
6,696,410 →
Application:
09/672,224 →
Repair of Larynx, Trachea, and Other Fibrocartilaginous Tissues
Matrix-Free Osteogenic Devices, Implants and Methods of Use Thereof
Terminally Sterilized Osteogenic Devices and Preparation Thereof
Methods of Identifying Morphogen Receptor-Binding Analogs
Methods and Compositions for Identifying Morphogenic Protein Analogs Using Morphogenic Protein Responsive Inhibitory Elements
Novel Therapies for Chronic Renal Failure
Synergistic Effects of Op/Bmp Morphogens and Gdnf/Ngf Neurotrophic Factors
Devices and Methods for Repair of Larynx, Trachea and Other Fibrocartilaginous Tissues
Osteogenic Devices and Methods of Use Thereof for Repair of Endochondral Bone and Osteochondral Defects
Modified Tgf-Beta Superfamily Protein
A Method for Repairing a Defect in an Intervertebral Disc
A Method and Device for Repairing the Larynx, Trachea and Other Fibrocartilaginous Tissues
Improved Osteogenic Devices and Methods of Use Thereof for Repair of Endochondral Bone, Osteochondral and Chondral Defects
Patent:
8,372,805 →
Application:
11/894,725 →
Repair of Ligament Using Osteogenic Proteins
Improved Osteogenic Devices and Methods of Use Thereof for Repair of Endochondral Bone, Osteochondral and Chondral Defects
Methods of treating cartilage defects using a soluble morphogenic protein complex
Application:
12/227,454 →
Publication:
US 2009/0298761
Novel Therapies for Chronic Renal Failure
Method for Repairing a Defect in an Intervertebral Disc
Patent:
42,954 →
Application:
12/558,093 →
Concentrated Protein Preparations of Bone Morphogenetic Proteins and Methods of Use Thereof
Methods for Detecting Neutralizing Antibodies for Bone Morphogenetic Proteins
Application:
12/679,965 →
Publication:
US 2010/0209926
Osteogenic Devices and Methods of Use Thereof for Repair of Endochondral Bone, Osteochondral and Chondral Defects
Methods of Treating Cartilage Defects
Application:
13/074,651 →
Publication:
US 2012/0077743
Therapies for Acute Renal Failure
Novel Therapies for Chronic Renal Failure
Methods of Treating Cartilage Defects
Application:
13/612,251 →
Publication:
US 2013/0231284
BMP Mutants with Decreased Susceptibility to Noggin
Application:
13/690,211 →
Publication:
US 2013/0184208
BMP-7 Variants with Reduced Immunogenicity
Application:
13/766,014 →
Publication:
US 2013/0190236
Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
Application:
13/782,138 →
Publication:
US 2014/0051632
Methods of Administering Bone Morphogenetic Protein Compositions
Application:
13/970,936 →
Publication:
US 2014/0200182
Methods for Detecting Neutralizing Antibodies for Bone Morphogenetic Proteins
Application:
13/975,065 →
Publication:
US 2014/0162273
Concentrated Protein Preparations of Bone Morphogenetic Proteins and Methods of Use Thereof
Application:
14/047,587 →
Buffers for Controlling the pH of Bone Morphogenetic Proteins
Application:
14/088,623 →
Publication:
US 2014/0336114
PERIPHERAL ADMINISTRATION OF PROTEINS INCLUDING TGF-beta SUPERFAMILY MEMBERS FOR TREATMENT OF SYSTEMIC DISORDERS AND DISEASE
Application:
14/186,545 →
Publication:
US 2014/0336595
Methods of Treating Cartilage Defects Using a Soluble Morphogenic Protein Complex
Application:
14/197,952 →
Publication:
US 2015/0057222
Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including Tgf-Beta Superfamily Members
Application:
14/215,232 →
Publication:
US 2014/0342976
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Apr 21, 2014
From: STRYKER CORPORATION
To: BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION
Reel/Frame 032716/0330 →
Release of Security Interest
Apr 21, 2014
From: BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION
To: STRYKER CORPORATION
Reel/Frame 032716/0522 →
Assignment of Assignor's Interest
Aug 14, 2014
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 033535/0440 →
Lien
Jan 8, 2016
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 037461/0778 →